Metallothionein-III prevents neuronal death and prolongs life span in amyotrophic lateral sclerosis model mice

Neuroscience

Volumn 189, Issue , 2011, Pages 293-298

  Hashimoto, K ^a,b   Hayashi, Y ^a   Watabe, K ^c   Inuzuka, T ^a   Hozumi, I ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Cu Zn superoxide dismutase; G93A; Growth inhibitory factor; Metallothionein III; Motor neuron

Indexed keywords

ADENOVIRUS VECTOR; COPPER ZINC SUPEROXIDE DISMUTASE; METALLOTHIONEIN III;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE EXPRESSION; LIFESPAN; LUMBAR SPINAL CORD; MOTONEURON; MOTOR PERFORMANCE; MOUSE; MOUSE MUTANT; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; CELL SURVIVAL; GENE THERAPY; GENETIC VECTORS; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MOTOR NEURONS; NERVE TISSUE PROTEINS; SPINAL CORD; SURVIVAL ANALYSIS;

EID: 79960900393     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.05.034     Document Type: Article

References (26)

1. Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S.M., Carmeliet P., Mazarakis N.D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004, 429:413-417.
2. Boillée S., Velde C.V., Cleveland D.W. ALS: a disease of motor neurons and their nonnneuronal neighbors. Neuron 2006, 52:39-59.
3. Bordet T., Lesbordes J.C., Rouhani S., Castelnau-Ptakhine L., Schmalbruch H., Haase G., Kahn A. Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. Hum Mol Genet 2001, 10:1925-1933.
4. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001, 2:806-819.
5. Hashimoto K., Hayashi Y., Inuzuka T., Hozumi I. Exercise induces metallothioneins in mouse spinal cord. Neuroscience 2009, 163:244-251.
6. Honda A., Komuro H., Hasegawa T., Seko Y., Shimada A., Nagase H., Hozumi I., Inuzuka T., Hara H., Fujiwara Y., Satoh M. Resistance of metallothionein-III null mice to cadmium-induced acute hepatotoxicity. J Toxicol Sci 2010, 35:209-215.
7. Honda A., Komuro H., Shimada A., Hasegawa T., Seko Y., Nagase H., Hozumi I., Inuzuka T., Hara H., Fujiwara Y., Satoh M. Attenuation of cadmium-induced testicular injury in metallothionein-III null mice. Life Sci 2010, 87:545-550.
8. Hozumi I., Asanuma M., Hiraiwa M., Uchida Y. Metallothioneins and neurodegenerative diseases. J Health Sci 2004, 50:323-331.
9. Hozumi I., Suzuki J.S., Kanazawa H., Hara A., Saio M., Inuzuka T., Miyairi S., Naganuma A., Tohyama C. Metallothionein-3 is expressed in the brain and various peripheral organs of the rat. Neurosci Lett 2008, 438:54-58.
10. Hozumi I., Uchida Y., Watabe K., Sakamoto T., Inuzuka T. Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci Lett 2006, 395:220-223.
11. Hozumi I., Yamada M., Uchida Y., Ozawa K., Takahashi H., Inuzuka T. The expression of metallothioneins is diminished in the spinal cords of patients with sporadic ALS. Amyotroph Lateral Scler 2008, 9:294-298.
12. Ishigaki S., Niwa J., Ando Y., Yoshihara T., Sawada K., Doyu M., Yamamoto M., Kato K., Yotsumoto Y., Sobue G. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 2002, 531:354-358.
13. Kaspar B.K., Lladó J., Sherkat N., Rothstein J.D., Gage F.H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003, 301:839-842.
14. Kirkinezos I.G., Hernandez D., Bradley W.G., Moraes C.T. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 2003, 53:804-807.
15. Mitchell J.D., Borasio G.D. Amyotrophic lateral sclerosis. Lancet 2007, 369:2031-2041.
16. Montoliu C., Monfort P., Carrasco J., Palacios O., Capdevila M., Hidalgo J., Felipo V. Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons. J Neurochem 2000, 75:266-273.
17. Nakajima H., Uchida K., Kobayashi S., Inukai T., Yayama T., Sato R., Mwaka E., Baba H. Target muscles for retrograde gene delivery to specific spinal cord segments. Neurosci Lett 2008, 435:1-6.
18. Puttaparthi K., Gitomer W.L., Krishnan U., Son M., Rajendran B., Elliott J.L. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci 2002, 22:8790-8796.
19. Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J., Zambrowicz B.P., Palmiter R.D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994, 33:7250-7259.
20. Sakamoto T., Kawazoe Y., Uchida Y., Hozumi I., Inuzuka T., Watabe K. Growth inhibitory factor prevents degeneration of injured adult rat motoneurons. Neuroreport 2003, 14:2147-2151.
21. Sorenson E.J., Windbank A.J., Mandrekar J.N., Bamlet W.R., Appel S.H., Armon C., Barkhaus P.E., Bosch P., Boylan K., David W.S., Feldman E., Glass J., Gutmann L., Katz J., King W., Luciano C.A., McCluskey L.F., Nash S., Newman D.S., Pascuzzi R.M., Pioro E., Sams L.J., Scelsa S., Simpson E.P., Subramony S.H., Tiryaki E., Thornton C.A. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 2008, 71:1770-1775.
22. Tokuda E., Ono S., Ishige K., Naganuma A., Ito Y., Suzuki T. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis. Toxicology 2007, 229:33-41.
23. Uchida Y., Gomi F., Masumizu T., Miura Y. Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J Biol Chem 2002, 277. 32353-32259.
24. Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991, 7:337-347.
25. Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., Nagatsu T., Ozawa K., Nakano I. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 2002, 22:6920-6928.
26. Wooley C.M., Sher R.B., Kale A., Frankel W.N., Cox G.A., Seburn K.L. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 2005, 32:43-50.